Lifecome Biochemistry Co Ltd (002868) — Tangible Net Worth Ratio
Lifecome Biochemistry Co Ltd (002868) has a Tangible Net Worth Ratio of 70.9% as of June 2026. This metric is calculated by deducting intangible assets (CN¥21.08 Million) from net assets (CN¥72.35 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Lifecome Biochemistry Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Lifecome Biochemistry Co Ltd Tangible Net Worth Ratio (2012–2025)
This chart shows how Lifecome Biochemistry Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 70.9%, reflecting net assets of CN¥72.35 Million with intangible assets of CN¥21.08 Million CNY. For live market cap and overall valuation, see 002868 company net worth.
Annual Tangible Net Worth Ratio for Lifecome Biochemistry Co Ltd (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Lifecome Biochemistry Co Ltd from 2012 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 002868 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.5% | CN¥64.93 Million | CN¥21.08 Million | CN¥748.71 Million | ▼ -0.5 pp |
| 2023 | 68.1% | CN¥414.11 Million | CN¥132.21 Million | CN¥1.97 Billion | ▼ -26.7 pp |
| 2022 | 94.8% | CN¥599.30 Million | CN¥31.40 Million | CN¥1.24 Billion | ▲ +0.4 pp |
| 2021 | 94.3% | CN¥722.02 Million | CN¥40.86 Million | CN¥1.26 Billion | ▼ -0.2 pp |
| 2020 | 94.5% | CN¥769.94 Million | CN¥42.08 Million | CN¥972.50 Million | ▼ -1.1 pp |
| 2019 | 95.7% | CN¥778.50 Million | CN¥33.82 Million | CN¥1.01 Billion | ▲ +0.2 pp |
| 2018 | 95.5% | CN¥740.37 Million | CN¥33.65 Million | CN¥802.42 Million | ▼ -2.6 pp |
| 2017 | 98.0% | CN¥695.68 Million | CN¥13.74 Million | CN¥756.25 Million | ▲ +3.1 pp |
| 2016 | 94.9% | CN¥271.34 Million | CN¥13.77 Million | CN¥370.66 Million | ▲ +0.9 pp |
| 2015 | 94.0% | CN¥238.98 Million | CN¥14.25 Million | CN¥392.52 Million | ▼ -1.4 pp |
| 2014 | 95.4% | CN¥190.87 Million | CN¥8.79 Million | CN¥390.09 Million | ▼ -0.1 pp |
| 2013 | 95.5% | CN¥169.42 Million | CN¥7.56 Million | CN¥395.88 Million | ▲ +0.3 pp |
| 2012 | 95.2% | CN¥156.45 Million | CN¥7.46 Million | CN¥371.37 Million | — |